To assist in the development of tools for antibiotic stewardship at local, national and global levels and to reduce antimicrobial resistance, the Access,...

The AWaRe Classification of antibiotics was developed in 2017 by the WHO Expert Committee on Selection and Use of Essential Medicines as a tool to support...

2023 Antibacterial agents in clinical and preclinical development: an overview and analysis

The World Health Organization’s (WHO) “2023 Antibacterial agents in clinical and preclinical development: an overview and analysis” report...

A case study on the ecosystem for local production of pharmaceuticals, vaccines and biologicals - The Bangladesh context

The Local Production and Assistance (LPA) Unit in the Regulation and Prequalification Department (RPQ), Access to Medicines and Health Products Division...

The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use

The AWaRe classification is intended as a tool for monitoring antibiotic use, defining targets and monitoring the impact of stewardship policies and interventions...